BORDERLINE RESECTABLE PANCREATIC CANCER: Need for Standardization and Methods for Optimal Clinical Trial Design

Methodological limitations of prior studies have prevented progress in the treatment of patients with borderline resectable pancreatic adenocarcinoma. Shortcomings have included the absence of staging and treatment standards and pre-existing biases with regard to the use of neoadjuvant therapy and t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Surg Oncol
Autori principali: Katz, Matthew HG, Marsh, Robert, Herman, Joseph M., Shi, Qian, Collison, Eric, Venook, Alan, Kindler, Hedy, Alberts, Steven, Philip, Philip, Lowy, Andrew M., Pisters, Peter, Posner, Mitchell, Berlin, Jordan, Ahmad, Syed A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600517/
https://ncbi.nlm.nih.gov/pubmed/23435609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2886-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi